Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Probiotics × Clear all

Phase

Status

Completed 17 Recruiting 12 Unknown 10 Not yet recruiting 2 Active not recruiting 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Generalized Anxiety Disorder 1

Interventions

Cyclophosphamide 342 Carboplatin 289 pembrolizumab 271 Gemcitabine 271 Cisplatin 266 Radiotherapy 256 Paclitaxel 254 Docetaxel 248 Bevacizumab 214 Rituximab 201 Capecitabine 190 Nivolumab 180 Dexamethasone 173 Fluorouracil 170 fludarabine 156 Oxaliplatin 150 Doxorubicin 136 Irinotecan 128 Leucovorin 127 Etoposide 123 Pemetrexed 122 Cytarabine 122 Bortezomib 111 fludarabine phosphate 110 Lenalidomide 107 Cetuximab 107 Filgrastim 104 Erlotinib Hydrochloride 99 Temozolomide 95 Trastuzumab 94

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04784182 2023-08-24

ABBCS

Auburn University

Phase NA Terminated

3 enrolled 10 charts

Generalized Anxiety Disorder

Data powered by HemOnc (CC BY 4.0) Colophon ⚡